Back to EARNEST PARTNERS LLC EARNEST PARTNERS LLC

MYGNMYGN
Showing 4 of 24 quarters

Position history for EARNEST PARTNERS LLCEARNEST PARTNERS LLC's holdings in MYRIAD GENETICS INC

No. Earnest Partners exited its MYGN (Myriad Genetics) position in Q2 2025. Its Q1 2025 13F listed 3,977,292 shares worth $35.3M. Earnest Partners first reported MYGN in Q3 2019 and held it in 23 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$108.4M

Total Shares Change

-4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$5.31
0
2025-Q1
Increased
4M
+0.1%
$35.3M0.2%$8.87
35
2024-Q4
Increased
4M
+0.4%
$54.5M0.2%$13.71
35
2024-Q3
Decreased
4M
-2.9%
$108.4M0.5%$27.39
0

Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used